logo

Analyzing the Impact of Earnings Reports on Autolus Therapeutics plc ADR Inc. (AUTL) Price Performance

CROX

Investors have been left with mixed emotions regarding the stock price performance over the year, as it’s been a mixed bag. Until today this year the stock’s price performance recorded a decrease of -37.89%. However, over the last six months, the performance has been stronger by 0.00%. The price of AUTL increased 11.11% over the last 30 days. And in the last five days, it has fallen by -10.51%.

Autolus Therapeutics plc ADR had a pretty favorable run when it comes to the market performance. Over the past year, the company’s stock reached a high of $7.45 on 01/12/24, while the lowest price during the same period was $2.56 on 10/31/23.

3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free
Sponsored

52-week price history of AUTL Stock

A stock’s 52-week price history, including the low and high prices, can offer valuable insights into its current standing and future prospects. Autolus Therapeutics plc ADR’s current trading price is -46.31% away from its 52-week high, while its distance from the 52-week low is 56.56%. The stock’s price range over this timeframe has been between $2.56 and $7.45. The shares of the Healthcare sector company recorded a trading volume of approximately 1.73 million for the day, which was comparatively higher than the average daily volume of 0.81 million over the last three months.

The Connection Between Financial Performance and Market Capitalization

Autolus Therapeutics plc ADR (AUTL) has experienced a quarterly decline of -11.31% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.06B and boasts a workforce of 463 employees.

How Moving Averages and Trading Volume Data Work Together

Based on Barchart.com data, the company’s moving average over the 100-day period was 4.04, with a change in price of unch. Similarly, Autolus Therapeutics plc ADR recorded 1,040,647 in trading volume during the last 100 days, posting a change of unch.

AUTL’s Debt-to-Equity Ratio: A Comprehensive Review

A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for AUTL stands at 0.55. Similarly, the long-term debt-to-equity ratio is also 0.54.

AUTL Stock Stochastic Average

Autolus Therapeutics plc ADR’s raw stochastic average for the past 50 days is currently at 38.46%. This represents a surge from the raw stochastic average of the last 20 days, which was recorded at 16.67%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 46.63% and 57.91%, respectively.

Most Popular